Increasing Oral Medication Adherence for Metastatic Breast Cancer Patients

Recruiting now

Conditions studied: Breast Cancer

In brief

Aim of this study is to optimize an adherence increasing intervention designed for metastatic Breast Cancer (BC) patients by applying a full factorial design in order to evaluate the optimal combination of three different intervention components.

Key facts

Study ID

NCT06726889

Run by

European Institute of Oncology

People needed

104

Starts

2024-01-25

Expected to finish

2025-04-01

Last updated by the study team

2024-12-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with a diagnosis of metastatic BC
• Patients with a prescription for any OAA (i.e. oral chemotherapy, endocrine therapy, and Cyclin-Dependent Kinase 4/6 Inhibitors)
• Age >18 years old
• Patients with a personal smart phone with internet access
• Willingness and ability to comply with scheduled visits and other trial procedures
• Understanding and speaking Italian language
• Written informed consent

You may not qualify if…

• Psychiatric disorders or conditions that might impair the ability to give informed consent
• Comorbidity that may impact on compliance to study procedures

Where it is running

• European Institute of Oncology — Milan, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.